How we work

We constantly push ourselves in the pursuit of better – better solutions, better processes and better ways of working that help our clients navigate complexity and make better decisions with greater confidence

We recognise that the journey is often as important as the destination. We work like an extension of your team so your overall journey with us feels better

Our Values

Our culture is founded on a strong set of values that guide how we work with each other and our clients. We are a passionate team who believe in collaborative spirit and a can-do attitude. We build bold solutions and make insightful recommendations because we dig deeper and remain constantly curious, to provide positive challenge and fresh thinking.

Our Values

With a global perspective

We work with 24 of the top 25 pharmaceutical clients globally from our offices in the US and Europe

Our locations

Teams of experts

We are expert navigators helping steer our clients to more successful outcomes

Our people

Solving unique problems

We love the challenge of working on the industry's newest and most complex problems

Job openings

Expert Navigation

Explore case studies that bring to life how we’ve uncovered hidden insights, explored scientific options and helped make difficult strategic choices

Case studies
Engaging with people and their stories of life with a Rare Disease
Engaging with people and their stories of life with a Rare Disease
I have worked on multiple Rare Disease projects throughout my career in the Biopharmaceutical and Consulting industry but I am still blown away by the strength, bravery and hope of those impacted by these rare and devastating conditions.
"What are my chances of surviving cancer?"
We are all touched by cancer; as an individual battling cancer, as a survivor of cancer or as a friend or family member of someone faced with the disease.
It’s time for some new language and models for healthcare marketing
It’s time for some new language and models for healthcare marketing
Healthcare brands need some new terminology and new models argues Giles Lury in his thinking piece for pharmaphorum. He suggests much of the current terminology for target audiences is no longer really fit for purpose and that too many of the maps are still rooted in old fashioned FMCG thinking.